Skip to main content
SpringerLink
Log in

Repetitive Thoughts and Behavior in Pervasive Developmental Disorders

Phenomenology and Pharmacotherapy

  • Chapter
Asperger Syndrome or High-Functioning Autism?

Part of the book series: Current Issues in Autism ((CIAM))

Overview

The repetitive thoughts and behavior of patients with pervasive developmental disorder(s) [PDD(s)] can be quite interfering, often disrupting educational and vocational opportunities, as well as general quality of life for the individual and family members. To date, results from studies designed to differentiate the nature of repetitive thoughts and behavior in specific subtypes of PDD, such as Asperger’s disorder, have not been published. Recent data indicate that drugs that are potent inhibitors of serotonin [5-hydroxytryptamine (5-HT)] neuronal uptake may be effective for reducing repetitive thoughts and behavior in some children, adolescents, and adults with PDDs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

    Google Scholar 

  • Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885–900.

    Article  PubMed  Google Scholar 

  • Baron-Cohen, S. (1989). Do autistic children have obsessions and compulsions? British Journal of Clinical Psychology, 28, 193–200.

    Article  PubMed  Google Scholar 

  • Benfield, P., & Ward, A. (1986). Fluvoxamine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs, 32, 313–334.

    Article  PubMed  Google Scholar 

  • Benkelfat, C., Murphy, D. L., Zohar, J., Hill, J. L., Grover, G., & Insel, T. R. (1989). Clomipramine in obsessive-compulsive disorder: Further evidence for a serotonergic mechanism of action. Archives of General Psychiatry, 46, 23–28.

    Article  PubMed  Google Scholar 

  • Brasic, J. R., Barnett, J. Y., Kaplan, D., Sheitman, B. B., Aisemberg, P., Lafargue, R. T., Kowalik, S., Clark, A., Tsaltas, M. O., & Young, J. G. (1994). Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. Neurology, 44, 1309–1312.

    Article  PubMed  Google Scholar 

  • Brodkin, E. S., McDougle, C. J., Naylor, S. T., Cohen, D. J., & Price, L. H. (1997). Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Child and Adolescent Psychopharmacology, 7,109–121.

    Article  PubMed  Google Scholar 

  • Brown, G. L., Goodwin, F. K., Ballenger, J. C., Goyer, P. F., & Major, L. F. (1979). Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Research, 1, 131–139.

    Article  PubMed  Google Scholar 

  • Ciaranello, A. L., & Ciaranello, R. D. (1995). The neurobiology of infantile autism. Annual Review of Neuroscience, 18, 101–128.

    Article  PubMed  Google Scholar 

  • Cook, E. H., Jr., Perry, B. D., Dawson, G., Wainwright, M. S., & Leventhal, B. L. (1993). Receptor inhibition by immunoglobulins: Specific inhibition by autistic children, their relatives, and control subjects. Journal of Autism and Developmental Disorders, 23, 67–78.

    Article  PubMed  Google Scholar 

  • Cook, E. H., Jr., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.

    Article  PubMed  Google Scholar 

  • Delgado, P. L., Price, L. H., Chantey, D. S., & Heninger, G. R. (1988). Efficacy of fluvoxamine in treatment-resistant depression. Journal ofAffective Disorders, 15, 55–60.

    Article  Google Scholar 

  • El Mansari, M., Bouchard, C., & Blier, P. (1994). Alteration of serotonin release in the orbito-frontal cortex by paroxetine. Relevance to obsessive-compulsive disorder. Proceedings of the Society for Neuroscience, 20(1), 226.

    Google Scholar 

  • Flament, M. F., Rapoport, J. L., Murphy, D. L., Berg, C. J., & Lake, C. R. (1987). Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Archives of General Psychiatry, 44, 219–225.

    Article  PubMed  Google Scholar 

  • Foa, E. B. (1979). Failures in treating obsessive-compulsives. Behavioral Research and Therapy, 7, 169–176.

    Article  Google Scholar 

  • Freeman, B. J., Ritvo, E. R., Yokota, A., & Ritvo, A. (1986). A scale for rating symptoms of patients with the syndrome of autism in real life settings. Journal of the American Academy of Child and Adolescent Psychiatry, 25, 130–136.

    Article  Google Scholar 

  • Garber, H. J., McGonigle, J. J., Slomka, G. T., & Monteverde, E. (1992). Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1157–1160.

    Article  PubMed  Google Scholar 

  • Ghaziuddin, M., Tsai, L., & Ghaziuddin, N. (1991). Fluoxetine in autism with depression [Letter]. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 3.

    Google Scholar 

  • Goodman, W. K., McDougle, C. J., Price, L. H., Riddle, M. A., Pauls, D. L., & Leckman, J. F. (1990). Beyond the serotonin hypothesis: A role for dopamine in some forms of obsessive compulsive disorder? Journal of Clinical Psychiatry, 51(Suppl. 8), 36–43.

    PubMed  Google Scholar 

  • Goodman, W. K., Price, L. H., Delgado, P. L., Palumbo, J., Krystal, J. H., Nagy, L. M., Rasmussen, S. A., Heninger, G. R., & Chamey, D. S. (1990). Specificity of serotonin reuptake inhibtors in the treatment of obsessive compulsive disorder: Comparison of fluvoxamine and desipramine. Archives of General Psychiatry, 47, 577–585.

    Article  PubMed  Google Scholar 

  • Goodman, W. K., Price, L. H., Rasmussen, S. A., Delgado, P. L., Heninger, G. R., & Chantey, D. S. (1989). Efficacy of fluvoxamine in obsessive-compulsive disorder: A double-blind comparison with placebo. Archives of General Psychiatry, 46, 36–43.

    Article  PubMed  Google Scholar 

  • Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Chamey, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part II. Validity. Archives of General Psychiatry, 46, 1012–1016.

    Article  PubMed  Google Scholar 

  • Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R., Hill, C., Heninger, G. R., & Chamey, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006–1011.

    Article  PubMed  Google Scholar 

  • Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.

    Article  PubMed  Google Scholar 

  • Greist, J., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. W., Koran, L., Liebowitz, M., Lydiard, R. B., Rasmussen, S., White, K., & Sikes, C. (1995). Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Archives of General Psychiatry, 52, 289–295.

    Article  PubMed  Google Scholar 

  • Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., & Serlin, R. C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Archives of General Psychiatry, 52, 53–60.

    Article  PubMed  Google Scholar 

  • Guy, W. (1976). ECDEU assessment manual for psychopharmacology (Publication 76–338). Washington, DC: U. S. Department of Health, Education, and Welfare.

    Google Scholar 

  • Hamdan-Allen, G. (1991). Brief report: Trichotillomania in an autistic male. Journal of Autism and Developmental Disorders, 21, 79–82.

    Article  PubMed  Google Scholar 

  • Hoder, E. L., & Cohen, D. J. (1983). Repetitive behavior patterns of childhood. In M. Levine & W. Carey (Eds.), Developmental-behavioral pediatrics (pp. 607–622). Philadelphia: Saunders.

    Google Scholar 

  • Hollander, E., DeCaria, C., Gully, R., Nitescu, A., Suckow, R. F., Gorman, J. M., Klein, D. F., & Liebowitz, M. R. (1991). Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to metachlorophenylpiperazine in obsessive compulsive disorder. Psychiatry Research, 36, 1–17.

    Article  PubMed  Google Scholar 

  • Hoshino, Y., Tachibana, J. R., Watanabe, M., Murata, S., Yokoyama, F., Kaneko, M., Yashima, Y., & Kumoshiro, H. (1984). Serotonin metabolism and hypothalamic pituitary function in children with infantile autism and minimal brain dysfunction. Japanese Journal of Psychiatry and Neurology, 26, 937–945.

    Google Scholar 

  • Kanner, L. (1943). Autistic disturbances of affective contact. Journal of Nervous Child, 2, 217–250.

    Google Scholar 

  • Krug, D. A., Arick, J. R., & Almond, P. J. (1980). Autism screening instrument for education planning. Portland, OR: ASIEP Educational Co.

    Google Scholar 

  • Le Couteur, A., Rutter, M., Lord, C., Rios, P., Robertson, S., Holdgrafer, M., & McLennan, J. (1989). Autism Diagnostic Interview: A standardized investigator-based instrument. Journal of Autism and Developmental Disorders, 19, 363–387.

    Article  PubMed  Google Scholar 

  • Leonard, H. L., Swedo, S. E., Rapoport, J. L., Coffey, M., & Cheslow, D. (1989). Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: A double-blind crossover comparison. Archives of General Psychiatry, 46, 1088–1092.

    Article  PubMed  Google Scholar 

  • Lindley, P., Marks, I., Philpott, R., & Snowden, J. (1977). Treatment of obsessive-compulsive neurosis with history of childhood autism. British Journal of Psychiatry, 130, 592–597.

    Article  PubMed  Google Scholar 

  • Lord, C., Rutter, M., Goode, S., Heemsbergen, J., Jordan, H., Mawhood, L., & Schopler, E. (1989). Autism Diagnostic Observation Schedule: A standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders, 19, 185–212.

    Article  PubMed  Google Scholar 

  • McBride, P. A., Anderson, G. M., Hertzig, M. E., Sweeney, J. A., Kream, J., Cohen, D. J., & Mann, J. J. (1989). Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Archives of General Psychiatry, 46, 213–221.

    Article  Google Scholar 

  • McDougle, C. J. (1997). Psychopharmacology. In D. J. Cohen & F. R. Volkmar (Eds.), Handbook of autism and pervasive developmental disorders (2nd ed.), (pp. 707–729). New York: Wiley

    Google Scholar 

  • McDougle, C. J., Brodkin, E. S., Naylor, S. T., Carlson, D., Cohen, D. J. & Price, L. H. (1998). Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation. Journal of Clinical Psychopharmacology, 18, 62–66.

    Article  Google Scholar 

  • McDougle, C. J., Goodman, W. K., Leckman, I. F., & Price, L. H. (1993). The psychopharmacology of obsessive compulsive disorder: Implications for treatment and pathogenesis. In D. L. Dunner (Ed.), Psychopharmacology 11 (Clinics of North America, Vol. 16) (pp. 749–766). Philadelphia: Saunders.

    Google Scholar 

  • McDougle, C. J., Kresch, L. E., Goodman, W. K., Naylor, S. T., Volkmar, F. R., Cohen, D. J., & Price, L. H. (1995). A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. American Journal of Psychiatry. 152, 772–777.

    Google Scholar 

  • McDougle, C. J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996). Effects of tryptophan depletion in drug-free adults with autism. Archives of General Psychiatry, 53, 993–1000.

    Article  Google Scholar 

  • McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.

    Article  Google Scholar 

  • McDougle, C. J., Price, L. H., & Goodman, W. K. (1990). Fluvoxamine treatment of coincident autistic disorder and obsessive compulsive disorder: A case report. Journal of Autism and Developmental Disorders, 20, 537–543.

    Article  Google Scholar 

  • McDougle, C. J., Price, L. H., Volkmar, F. R., Goodman, W. K., Ward-O’Brien, D., Nielsen, J., Bregman, J., & Cohen, D. J. (1992). Clomipramine in autism: Preliminary evidence of efficacy. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 746–750.

    Article  Google Scholar 

  • Mehlinger, R., Scheftner, W. A., & Poznanski, E. (1990). Fluoxetine and autism [Letter]. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 1985.

    Article  Google Scholar 

  • Prior, M., & Macmillan, M. B. (1973). Maintenance of sameness in children with Kanner’s syndrome. Journal of Autism and Childhood Schizophrenia, 3, 154–167.

    Article  PubMed  Google Scholar 

  • Rapoport, J. L., Swedo, S. E., & Leonard, H. L. (1992). Childhood obsessive-compulsive disorder. Journal of Clinical Psychiatry, 53, 11–16.

    PubMed  Google Scholar 

  • Riddle, M. A., Geller, B., & Ryan, N. (1993). Another sudden death in a child treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 792–797.

    Article  PubMed  Google Scholar 

  • Rumsey, J. M., Rapoport, J. L., & Sceery, W. R. (1985). Autistic children as adults: Psychiatric, social, and behavioral outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 465–473.

    Article  Google Scholar 

  • Sanchez, L. E., Campbell, M., Small, A. M., Cueva, J. E., Armenteros, J. L., & Adams, P. B. (1996). A pilot study of clomipramine in young autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 537–544.

    Article  PubMed  Google Scholar 

  • Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 58, 315–320.

    Article  PubMed  Google Scholar 

  • Smalley, S. L., McCracken, J., & Tanguay, R. (1995). Autism, affective disorders, and social phobia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 60, 19–26.

    Article  Google Scholar 

  • Sparrow, S. S., Balla, D. A., & Cicchetti, D. V. (1984). Vineland Adaptive Behavior Scales (A revision ofthe Vineland Social Maturity Scale by Edgar A. Doll). Circle Pines, MN: American Guidance Service.

    Google Scholar 

  • Steingard, R. J., Zimnitzky, B., DeMaso, D. R., Bauman, M. L., & Bucci, J. P. (1997). Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 7, 9–15.

    Article  PubMed  Google Scholar 

  • Thoren, P. M., Asberg, M., Cronholm, B., Jomestedt, L., & Traskman, L. (1980). Clomipramine treatment of obsessive-compulsive disorder, I: A controlled clinical trial. Archives of General Psychiatry, 37, 1281–1285.

    Article  PubMed  Google Scholar 

  • Todd, R. D. (1991). Fluoxetine in autism [Letter]. American Journal of Psychiatry, 148, 1089.

    PubMed  Google Scholar 

  • Todd, R. D., & Ciaranello, R. D. (1985). Demonstration of inter-and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of the National Academy of Sciences USA, 82, 612–616.

    Article  Google Scholar 

  • Tollefson, G. D., Rampey, A. H., Jr., Potvin, J. H., Jenike, M. A., Rush, A. J., Dominguez, R. A., Koran, L. M., Shear, M. K., Goodman, W., & Genduso, L. A. (1994). A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51, 559–567.

    Article  PubMed  Google Scholar 

  • van Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1994). Psychopharmacological treatment of social phobia: A double-blind placebo-controlled study with fluvoxamine. Psychopharmacology, 115, 128–134.

    Article  PubMed  Google Scholar 

  • Volkmar, F. R., Hoder, E. L., & Cohen, D. J. (1985). Compliance, ‘negativism,’ and the effects of treatment structure in autism: A naturalistic, behavioral study. Journal of Child Psychology and Psychiatry, 26, 865–877.

    Article  PubMed  Google Scholar 

  • Volkmar, F. R., & Nelson, D. S. (1990). Seizure disorders in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 1, 127–129.

    Article  Google Scholar 

  • Wheadon, D. E., Bushnell, W. D., & Steiner, M. (1993). A fixed-dose comparison of 20,40 or 60 mg paroxetine to placebo in the treatment of obsessive-compulsive disorder. Proceedings of the American College of Neuropsychopharmacology Annual Meeting.

    Google Scholar 

  • Yuwiler, A., Shih, J. C., Chen, C.-H., Ritvo, E. R., Hanna, G., Ellison, G.-W., & King, B. H. (1992). Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of Autism and Developmental Disorders, 82, 612–616.

    Google Scholar 

  • Zohar, J., & Insel, T. R. (1987). Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry, 22, 667–687.

    Article  PubMed  Google Scholar 

  • Zohar, J., Insel, T. R., Zohar-Kadouch, R. C., Hill, J. L., & Murphy, D. L. (1988). Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Archives of General Psychiatry, 45, 167–172.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Child and Adolescent Psychiatry, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, 46202, USA

    Christopher J. McDougle

Authors
  1. Christopher J. McDougle
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division TEACCH, Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7180, USA

    Eric Schopler  & Gary B. Mesibov  & 

  2. Illinois Wesleyan University, Bloomington, Illinois, 61702-2900, USA

    Linda J. Kunce

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

McDougle, C.J. (1998). Repetitive Thoughts and Behavior in Pervasive Developmental Disorders. In: Schopler, E., Mesibov, G.B., Kunce, L.J. (eds) Asperger Syndrome or High-Functioning Autism?. Current Issues in Autism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5369-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5369-4_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7450-3

  • Online ISBN: 978-1-4615-5369-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation